4//SEC Filing
Colleran David 4
Accession 0001171843-24-001306
CIK 0000898437other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 8:03 PM ET
Size
21.1 KB
Accession
0001171843-24-001306
Insider Transaction Report
Form 4
Colleran David
EVP, General Counsel, Corp Sec
Transactions
- Tax Payment
Common Stock
2024-03-11$25.79/sh−2,250$58,028→ 32,995 total - Exercise/Conversion
Restricted Stock Unit
2024-03-11−3,682→ 0 totalExercise: $0.00→ Common Stock (3,682 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-03-11−5,465→ 10,930 totalExercise: $0.00→ Common Stock (5,465 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-03-11−7,662→ 7,663 totalExercise: $0.00→ Common Stock (7,662 underlying) - Exercise/Conversion
Common Stock
2024-03-11+3,682→ 24,804 total - Tax Payment
Common Stock
2024-03-11$25.42/sh−1,081$27,479→ 23,723 total - Exercise/Conversion
Common Stock
2024-03-11+5,465→ 29,188 total - Tax Payment
Common Stock
2024-03-11$25.42/sh−1,605$40,799→ 27,583 total - Exercise/Conversion
Common Stock
2024-03-11+7,662→ 35,245 total
Footnotes (12)
- [F1]Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.
- [F10]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022.
- [F11]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.
- [F12]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023.
- [F2]Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 642 shares on May 12, 2023 and 192 shares on November 14, 2023.
- [F3]Reflects an aggregate of 1,081 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.
- [F4]Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.
- [F5]Reflects the first vesting installment of RSUs granted on March 9, 2023.
- [F6]Reflects an aggregate of 1,605 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.
- [F7]Reflects the second vesting installment of RSUs granted on March 11, 2022.
- [F8]Reflects an aggregate of 2,250 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2024.
- [F9]Reflects the closing price of ANIK common stock on March 11, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001646558
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 8:03 PM ET
- Size
- 21.1 KB